Renaissance Technologies — Unmapped CUSIP

How Renaissance Technologies's position in Kalaris Therapeutics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 482929106 needs mapping

Quarters held

2

First reported

Q1 2026

Latest value

$607,859

Latest weight

0%

Peak weight

0%

Shares since first

+125.8%

Position Trend

Shares, value, and weight from first report to latest report.

Renaissance Technologies first reported 66,151 shares in Q1 2026 and most recently reported 149,351 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q2 2026.

Since the first report, shares are +125.8% and reported value is +59.3%. Latest move: ADD